News &
Notifications
All Categories
Halfhearted bill of the Minister of Justice
Your Contact
Michael Diegelmann
+49 611 20 58 55 ...
04 July 2019 | DEAG: Convertible bond 2016/2019 fully converted into shares" width="172" height="174" data-ratio="1.0116279069767"/>04 July 2019 | DEAG: Convertible bond 2016/2019 fully converted into shares
Berlin, 4 July 2019 – DEAG Deutsche Entertainment Aktiengesellschaft (DEAG), Berlin, (ISIN: DE000A0Z23G6 | Ticker Symbol: ERMK), has announced that all convertible bonds (ISIN DE000A2AAX86) with a total par value of EUR 4,300,000.00 have been converted into new no-par value ordinary bearer shares of DEAG (the “shares”). This equates to 1,228,553 shares on the basis of the conversion ratio defined in the bond terms. In today's mandatory conversion, an additional 571,420 shares were generated, resulting in a new total of 19,625,976 shares.
04. Juli 2019 | creditshelf on strong growth path" width="172" height="174" data-ratio="1.0116279069767"/>04. Juli 2019 | creditshelf on strong growth path
Frankfurt am Main, Germany, 04 July 2019 - creditshelf Aktiengesellschaft, a pioneer in digital SME financing in Germany, managed to more than double its arranged loan volume in the first half 2019 compared with the same period of the previous year. The positive development of its loan business in the first half 2019 is reflected in the following numbers:
Michael Diegelmann in BörseOnline from June 27, 2019: “Employee representatives should work in the supervisory boards towards more investments”.
Your Contact
Michael Diegelmann
+49 611 20 58 55 ...
02. Juli 2019 | Manz AG successfully holds 2019 Annual General Meeting" width="172" height="174" data-ratio="1.0116279069767"/>02. Juli 2019 | Manz AG successfully holds 2019 Annual General Meeting
Manz AG, a global high-tech equipment manufacturer with a comprehensive technology portfolio, held its 2019 annual general meeting on Tuesday at the FILharmonie in Filderstadt. The presence of the represented share capital equaled approximately 60,35 %; all of the agenda items were adopted by a large majority.
The board used the opportunity to report the operational and strategic development of Manz AG for fiscal year 2018 to the shareholders in detail. The past year was characterized by clear advances in the sustainable increase of Manz AG’s competitiveness and profitability. Due to direct organizational and process improvements as well as the optimized product portfolio, sales as well as the result improved significantly compared to the previous year. In this context, the board thanked all of its employees for successful efforts over the past years.
01. Juli 2019 | Dermapharm Holding SE with increased free float" width="172" height="174" data-ratio="1.0116279069767"/>01. Juli 2019 | Dermapharm Holding SE with increased free float
Grünwald, July 1, 2019 – Dermapharm Holding SE ("Dermapharm"), a leading manufacturer of patent-free branded drugs for selected therapeutic areas in Germany with a growing international presence, has been informed by Themis Beteiligungs-Aktiengesellschaft ("Themis") that on June 28, 2019 580,000 shares of Dermapharm for the price of 30.00 Euros per share have been sold outside a trading venue.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
